“Whether these antibodies might also have a role in milder syndromes, or perhaps in cryptogenic epilepsy, warrants further study,” Lawrence J. Hirsch, MD, wrote in an accompanying editorial.
This preliminary study could not determine which, if any, antiepileptic drugs might be effective, nor which immunotherapies might be helpful. Future research should address those issues as well, said Dr. Hirsch, Professor of Neurology at Yale University in New Haven, Connecticut.
—Mary Ann Moon